Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Radiotheranostic Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Nuclear Reactors
1.2.3 Cyclotrons
1.3 Market by Application
1.3.1 Global Radiotheranostic Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Oncology
1.3.3 Non-Oncology
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Radiotheranostic Market Perspective (2018-2033)
2.2 Radiotheranostic Growth Trends by Region
2.2.1 Global Radiotheranostic Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Radiotheranostic Historic Market Size by Region (2018-2023)
2.2.3 Radiotheranostic Forecasted Market Size by Region (2024-2033)
2.3 Radiotheranostic Market Dynamics
2.3.1 Radiotheranostic Industry Trends
2.3.2 Radiotheranostic Market Drivers
2.3.3 Radiotheranostic Market Challenges
2.3.4 Radiotheranostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Radiotheranostic Players by Revenue
3.1.1 Global Top Radiotheranostic Players by Revenue (2018-2023)
3.1.2 Global Radiotheranostic Revenue Market Share by Players (2018-2023)
3.2 Global Radiotheranostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Radiotheranostic Revenue
3.4 Global Radiotheranostic Market Concentration Ratio
3.4.1 Global Radiotheranostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Radiotheranostic Revenue in 2022
3.5 Radiotheranostic Key Players Head office and Area Served
3.6 Key Players Radiotheranostic Product Solution and Service
3.7 Date of Enter into Radiotheranostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Radiotheranostic Breakdown Data by Type
4.1 Global Radiotheranostic Historic Market Size by Type (2018-2023)
4.2 Global Radiotheranostic Forecasted Market Size by Type (2024-2033)
5 Radiotheranostic Breakdown Data by Application
5.1 Global Radiotheranostic Historic Market Size by Application (2018-2023)
5.2 Global Radiotheranostic Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Radiotheranostic Market Size (2018-2033)
6.2 North America Radiotheranostic Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Radiotheranostic Market Size by Country (2018-2023)
6.4 North America Radiotheranostic Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Radiotheranostic Market Size (2018-2033)
7.2 Europe Radiotheranostic Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Radiotheranostic Market Size by Country (2018-2023)
7.4 Europe Radiotheranostic Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Radiotheranostic Market Size (2018-2033)
8.2 Asia-Pacific Radiotheranostic Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Radiotheranostic Market Size by Region (2018-2023)
8.4 Asia-Pacific Radiotheranostic Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Radiotheranostic Market Size (2018-2033)
9.2 Latin America Radiotheranostic Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Radiotheranostic Market Size by Country (2018-2023)
9.4 Latin America Radiotheranostic Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Radiotheranostic Market Size (2018-2033)
10.2 Middle East & Africa Radiotheranostic Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Radiotheranostic Market Size by Country (2018-2023)
10.4 Middle East & Africa Radiotheranostic Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ITM Isotopen Technologien München AG
11.1.1 ITM Isotopen Technologien München AG Company Detail
11.1.2 ITM Isotopen Technologien München AG Business Overview
11.1.3 ITM Isotopen Technologien München AG Radiotheranostic Introduction
11.1.4 ITM Isotopen Technologien München AG Revenue in Radiotheranostic Business (2018-2023)
11.1.5 ITM Isotopen Technologien München AG Recent Development
11.2 Advanced Accelerator Applications
11.2.1 Advanced Accelerator Applications Company Detail
11.2.2 Advanced Accelerator Applications Business Overview
11.2.3 Advanced Accelerator Applications Radiotheranostic Introduction
11.2.4 Advanced Accelerator Applications Revenue in Radiotheranostic Business (2018-2023)
11.2.5 Advanced Accelerator Applications Recent Development
11.3 Telix Pharmaceuticals
11.3.1 Telix Pharmaceuticals Company Detail
11.3.2 Telix Pharmaceuticals Business Overview
11.3.3 Telix Pharmaceuticals Radiotheranostic Introduction
11.3.4 Telix Pharmaceuticals Revenue in Radiotheranostic Business (2018-2023)
11.3.5 Telix Pharmaceuticals Recent Development
11.4 Theragnostics Ltd.
11.4.1 Theragnostics Ltd. Company Detail
11.4.2 Theragnostics Ltd. Business Overview
11.4.3 Theragnostics Ltd. Radiotheranostic Introduction
11.4.4 Theragnostics Ltd. Revenue in Radiotheranostic Business (2018-2023)
11.4.5 Theragnostics Ltd. Recent Development
11.5 NuView Life Sciences
11.5.1 NuView Life Sciences Company Detail
11.5.2 NuView Life Sciences Business Overview
11.5.3 NuView Life Sciences Radiotheranostic Introduction
11.5.4 NuView Life Sciences Revenue in Radiotheranostic Business (2018-2023)
11.5.5 NuView Life Sciences Recent Development
11.6 Jubilant Pharma Limited
11.6.1 Jubilant Pharma Limited Company Detail
11.6.2 Jubilant Pharma Limited Business Overview
11.6.3 Jubilant Pharma Limited Radiotheranostic Introduction
11.6.4 Jubilant Pharma Limited Revenue in Radiotheranostic Business (2018-2023)
11.6.5 Jubilant Pharma Limited Recent Development
11.7 Clarity Pharmaceuticals.
11.7.1 Clarity Pharmaceuticals. Company Detail
11.7.2 Clarity Pharmaceuticals. Business Overview
11.7.3 Clarity Pharmaceuticals. Radiotheranostic Introduction
11.7.4 Clarity Pharmaceuticals. Revenue in Radiotheranostic Business (2018-2023)
11.7.5 Clarity Pharmaceuticals. Recent Development
11.8 TransCode Therapeutics, Inc.
11.8.1 TransCode Therapeutics, Inc. Company Detail
11.8.2 TransCode Therapeutics, Inc. Business Overview
11.8.3 TransCode Therapeutics, Inc. Radiotheranostic Introduction
11.8.4 TransCode Therapeutics, Inc. Revenue in Radiotheranostic Business (2018-2023)
11.8.5 TransCode Therapeutics, Inc. Recent Development
11.9 Curium SAS
11.9.1 Curium SAS Company Detail
11.9.2 Curium SAS Business Overview
11.9.3 Curium SAS Radiotheranostic Introduction
11.9.4 Curium SAS Revenue in Radiotheranostic Business (2018-2023)
11.9.5 Curium SAS Recent Development
11.10 GE Healthcare Inc.
11.10.1 GE Healthcare Inc. Company Detail
11.10.2 GE Healthcare Inc. Business Overview
11.10.3 GE Healthcare Inc. Radiotheranostic Introduction
11.10.4 GE Healthcare Inc. Revenue in Radiotheranostic Business (2018-2023)
11.10.5 GE Healthcare Inc. Recent Development
11.11 Bayer AG
11.11.1 Bayer AG Company Detail
11.11.2 Bayer AG Business Overview
11.11.3 Bayer AG Radiotheranostic Introduction
11.11.4 Bayer AG Revenue in Radiotheranostic Business (2018-2023)
11.11.5 Bayer AG Recent Development
11.12 Lantheus Medical
11.12.1 Lantheus Medical Company Detail
11.12.2 Lantheus Medical Business Overview
11.12.3 Lantheus Medical Radiotheranostic Introduction
11.12.4 Lantheus Medical Revenue in Radiotheranostic Business (2018-2023)
11.12.5 Lantheus Medical Recent Development
11.13 Imaging, Inc.
11.13.1 Imaging, Inc. Company Detail
11.13.2 Imaging, Inc. Business Overview
11.13.3 Imaging, Inc. Radiotheranostic Introduction
11.13.4 Imaging, Inc. Revenue in Radiotheranostic Business (2018-2023)
11.13.5 Imaging, Inc. Recent Development
11.14 Novartis AG
11.14.1 Novartis AG Company Detail
11.14.2 Novartis AG Business Overview
11.14.3 Novartis AG Radiotheranostic Introduction
11.14.4 Novartis AG Revenue in Radiotheranostic Business (2018-2023)
11.14.5 Novartis AG Recent Development
11.15 Spectrum Pharmaceuticals, Inc.
11.15.1 Spectrum Pharmaceuticals, Inc. Company Detail
11.15.2 Spectrum Pharmaceuticals, Inc. Business Overview
11.15.3 Spectrum Pharmaceuticals, Inc. Radiotheranostic Introduction
11.15.4 Spectrum Pharmaceuticals, Inc. Revenue in Radiotheranostic Business (2018-2023)
11.15.5 Spectrum Pharmaceuticals, Inc. Recent Development
11.16 Ipsen S.A.
11.16.1 Ipsen S.A. Company Detail
11.16.2 Ipsen S.A. Business Overview
11.16.3 Ipsen S.A. Radiotheranostic Introduction
11.16.4 Ipsen S.A. Revenue in Radiotheranostic Business (2018-2023)
11.16.5 Ipsen S.A. Recent Development
11.17 Actinium Pharmaceuticals, Inc. (ATNM)
11.17.1 Actinium Pharmaceuticals, Inc. (ATNM) Company Detail
11.17.2 Actinium Pharmaceuticals, Inc. (ATNM) Business Overview
11.17.3 Actinium Pharmaceuticals, Inc. (ATNM) Radiotheranostic Introduction
11.17.4 Actinium Pharmaceuticals, Inc. (ATNM) Revenue in Radiotheranostic Business (2018-2023)
11.17.5 Actinium Pharmaceuticals, Inc. (ATNM) Recent Development
11.18 Nordic Nanovector ASA
11.18.1 Nordic Nanovector ASA Company Detail
11.18.2 Nordic Nanovector ASA Business Overview
11.18.3 Nordic Nanovector ASA Radiotheranostic Introduction
11.18.4 Nordic Nanovector ASA Revenue in Radiotheranostic Business (2018-2023)
11.18.5 Nordic Nanovector ASA Recent Development
11.19 Y-mAbs Therapeutics, Inc.
11.19.1 Y-mAbs Therapeutics, Inc. Company Detail
11.19.2 Y-mAbs Therapeutics, Inc. Business Overview
11.19.3 Y-mAbs Therapeutics, Inc. Radiotheranostic Introduction
11.19.4 Y-mAbs Therapeutics, Inc. Revenue in Radiotheranostic Business (2018-2023)
11.19.5 Y-mAbs Therapeutics, Inc. Recent Development
11.20 Sofie Biosciences, Inc.
11.20.1 Sofie Biosciences, Inc. Company Detail
11.20.2 Sofie Biosciences, Inc. Business Overview
11.20.3 Sofie Biosciences, Inc. Radiotheranostic Introduction
11.20.4 Sofie Biosciences, Inc. Revenue in Radiotheranostic Business (2018-2023)
11.20.5 Sofie Biosciences, Inc. Recent Development
11.21 Terumo Corporation
11.21.1 Terumo Corporation Company Detail
11.21.2 Terumo Corporation Business Overview
11.21.3 Terumo Corporation Radiotheranostic Introduction
11.21.4 Terumo Corporation Revenue in Radiotheranostic Business (2018-2023)
11.21.5 Terumo Corporation Recent Development
11.22 Sirtex Medical Limited
11.22.1 Sirtex Medical Limited Company Detail
11.22.2 Sirtex Medical Limited Business Overview
11.22.3 Sirtex Medical Limited Radiotheranostic Introduction
11.22.4 Sirtex Medical Limited Revenue in Radiotheranostic Business (2018-2023)
11.22.5 Sirtex Medical Limited Recent Development
11.23 Boston Scientific Corporation
11.23.1 Boston Scientific Corporation Company Detail
11.23.2 Boston Scientific Corporation Business Overview
11.23.3 Boston Scientific Corporation Radiotheranostic Introduction
11.23.4 Boston Scientific Corporation Revenue in Radiotheranostic Business (2018-2023)
11.23.5 Boston Scientific Corporation Recent Development
11.24 Nihon Medi-Physics
11.24.1 Nihon Medi-Physics Company Detail
11.24.2 Nihon Medi-Physics Business Overview
11.24.3 Nihon Medi-Physics Radiotheranostic Introduction
11.24.4 Nihon Medi-Physics Revenue in Radiotheranostic Business (2018-2023)
11.24.5 Nihon Medi-Physics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Radiotheranostic Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Nuclear Reactors
Table 3. Key Players of Cyclotrons
Table 4. Global Radiotheranostic Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Radiotheranostic Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Radiotheranostic Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Radiotheranostic Market Share by Region (2018-2023)
Table 8. Global Radiotheranostic Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Radiotheranostic Market Share by Region (2024-2033)
Table 10. Radiotheranostic Market Trends
Table 11. Radiotheranostic Market Drivers
Table 12. Radiotheranostic Market Challenges
Table 13. Radiotheranostic Market Restraints
Table 14. Global Radiotheranostic Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Radiotheranostic Market Share by Players (2018-2023)
Table 16. Global Top Radiotheranostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiotheranostic as of 2022)
Table 17. Ranking of Global Top Radiotheranostic Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Radiotheranostic Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Radiotheranostic Product Solution and Service
Table 21. Date of Enter into Radiotheranostic Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Radiotheranostic Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Radiotheranostic Revenue Market Share by Type (2018-2023)
Table 25. Global Radiotheranostic Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Radiotheranostic Revenue Market Share by Type (2024-2033)
Table 27. Global Radiotheranostic Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Radiotheranostic Revenue Market Share by Application (2018-2023)
Table 29. Global Radiotheranostic Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Radiotheranostic Revenue Market Share by Application (2024-2033)
Table 31. North America Radiotheranostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Radiotheranostic Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Radiotheranostic Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Radiotheranostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Radiotheranostic Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Radiotheranostic Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Radiotheranostic Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Radiotheranostic Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Radiotheranostic Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Radiotheranostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Radiotheranostic Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Radiotheranostic Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Radiotheranostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Radiotheranostic Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Radiotheranostic Market Size by Country (2024-2033) & (US$ Million)
Table 46. ITM Isotopen Technologien München AG Company Detail
Table 47. ITM Isotopen Technologien München AG Business Overview
Table 48. ITM Isotopen Technologien München AG Radiotheranostic Product
Table 49. ITM Isotopen Technologien München AG Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 50. ITM Isotopen Technologien München AG Recent Development
Table 51. Advanced Accelerator Applications Company Detail
Table 52. Advanced Accelerator Applications Business Overview
Table 53. Advanced Accelerator Applications Radiotheranostic Product
Table 54. Advanced Accelerator Applications Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 55. Advanced Accelerator Applications Recent Development
Table 56. Telix Pharmaceuticals Company Detail
Table 57. Telix Pharmaceuticals Business Overview
Table 58. Telix Pharmaceuticals Radiotheranostic Product
Table 59. Telix Pharmaceuticals Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 60. Telix Pharmaceuticals Recent Development
Table 61. Theragnostics Ltd. Company Detail
Table 62. Theragnostics Ltd. Business Overview
Table 63. Theragnostics Ltd. Radiotheranostic Product
Table 64. Theragnostics Ltd. Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 65. Theragnostics Ltd. Recent Development
Table 66. NuView Life Sciences Company Detail
Table 67. NuView Life Sciences Business Overview
Table 68. NuView Life Sciences Radiotheranostic Product
Table 69. NuView Life Sciences Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 70. NuView Life Sciences Recent Development
Table 71. Jubilant Pharma Limited Company Detail
Table 72. Jubilant Pharma Limited Business Overview
Table 73. Jubilant Pharma Limited Radiotheranostic Product
Table 74. Jubilant Pharma Limited Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 75. Jubilant Pharma Limited Recent Development
Table 76. Clarity Pharmaceuticals. Company Detail
Table 77. Clarity Pharmaceuticals. Business Overview
Table 78. Clarity Pharmaceuticals. Radiotheranostic Product
Table 79. Clarity Pharmaceuticals. Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 80. Clarity Pharmaceuticals. Recent Development
Table 81. TransCode Therapeutics, Inc. Company Detail
Table 82. TransCode Therapeutics, Inc. Business Overview
Table 83. TransCode Therapeutics, Inc. Radiotheranostic Product
Table 84. TransCode Therapeutics, Inc. Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 85. TransCode Therapeutics, Inc. Recent Development
Table 86. Curium SAS Company Detail
Table 87. Curium SAS Business Overview
Table 88. Curium SAS Radiotheranostic Product
Table 89. Curium SAS Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 90. Curium SAS Recent Development
Table 91. GE Healthcare Inc. Company Detail
Table 92. GE Healthcare Inc. Business Overview
Table 93. GE Healthcare Inc. Radiotheranostic Product
Table 94. GE Healthcare Inc. Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 95. GE Healthcare Inc. Recent Development
Table 96. Bayer AG Company Detail
Table 97. Bayer AG Business Overview
Table 98. Bayer AG Radiotheranostic Product
Table 99. Bayer AG Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 100. Bayer AG Recent Development
Table 101. Lantheus Medical Company Detail
Table 102. Lantheus Medical Business Overview
Table 103. Lantheus Medical Radiotheranostic Product
Table 104. Lantheus Medical Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 105. Lantheus Medical Recent Development
Table 106. Imaging, Inc. Company Detail
Table 107. Imaging, Inc. Business Overview
Table 108. Imaging, Inc. Radiotheranostic Product
Table 109. Imaging, Inc. Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 110. Imaging, Inc. Recent Development
Table 111. Novartis AG Company Detail
Table 112. Novartis AG Business Overview
Table 113. Novartis AG Radiotheranostic Product
Table 114. Novartis AG Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 115. Novartis AG Recent Development
Table 116. Spectrum Pharmaceuticals, Inc. Company Detail
Table 117. Spectrum Pharmaceuticals, Inc. Business Overview
Table 118. Spectrum Pharmaceuticals, Inc. Radiotheranostic Product
Table 119. Spectrum Pharmaceuticals, Inc. Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 120. Spectrum Pharmaceuticals, Inc. Recent Development
Table 121. Ipsen S.A. Company Detail
Table 122. Ipsen S.A. Business Overview
Table 123. Ipsen S.A. Radiotheranostic Product
Table 124. Ipsen S.A. Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 125. Ipsen S.A. Recent Development
Table 126. Actinium Pharmaceuticals, Inc. (ATNM) Company Detail
Table 127. Actinium Pharmaceuticals, Inc. (ATNM) Business Overview
Table 128. Actinium Pharmaceuticals, Inc. (ATNM) Radiotheranostic Product
Table 129. Actinium Pharmaceuticals, Inc. (ATNM) Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 130. Actinium Pharmaceuticals, Inc. (ATNM) Recent Development
Table 131. Nordic Nanovector ASA Company Detail
Table 132. Nordic Nanovector ASA Business Overview
Table 133. Nordic Nanovector ASA Radiotheranostic Product
Table 134. Nordic Nanovector ASA Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 135. Nordic Nanovector ASA Recent Development
Table 136. Y-mAbs Therapeutics, Inc. Company Detail
Table 137. Y-mAbs Therapeutics, Inc. Business Overview
Table 138. Y-mAbs Therapeutics, Inc. Radiotheranostic Product
Table 139. Y-mAbs Therapeutics, Inc. Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 140. Y-mAbs Therapeutics, Inc. Recent Development
Table 141. Sofie Biosciences, Inc. Company Detail
Table 142. Sofie Biosciences, Inc. Business Overview
Table 143. Sofie Biosciences, Inc. Radiotheranostic Product
Table 144. Sofie Biosciences, Inc. Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 145. Sofie Biosciences, Inc. Recent Development
Table 146. Terumo Corporation Company Detail
Table 147. Terumo Corporation Business Overview
Table 148. Terumo Corporation Radiotheranostic Product
Table 149. Terumo Corporation Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 150. Terumo Corporation Recent Development
Table 151. Sirtex Medical Limited Company Detail
Table 152. Sirtex Medical Limited Business Overview
Table 153. Sirtex Medical Limited Radiotheranostic Product
Table 154. Sirtex Medical Limited Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 155. Sirtex Medical Limited Recent Development
Table 156. Boston Scientific Corporation Company Detail
Table 157. Boston Scientific Corporation Business Overview
Table 158. Boston Scientific Corporation Radiotheranostic Product
Table 159. Boston Scientific Corporation Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 160. Boston Scientific Corporation Recent Development
Table 161. Nihon Medi-Physics Company Detail
Table 162. Nihon Medi-Physics Business Overview
Table 163. Nihon Medi-Physics Radiotheranostic Product
Table 164. Nihon Medi-Physics Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 165. Nihon Medi-Physics Recent Development
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Radiotheranostic Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Radiotheranostic Market Share by Type: 2022 VS 2033
Figure 3. Nuclear Reactors Features
Figure 4. Cyclotrons Features
Figure 5. Global Radiotheranostic Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Radiotheranostic Market Share by Application: 2022 VS 2033
Figure 7. Oncology Case Studies
Figure 8. Non-Oncology Case Studies
Figure 9. Radiotheranostic Report Years Considered
Figure 10. Global Radiotheranostic Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 11. Global Radiotheranostic Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 12. Global Radiotheranostic Market Share by Region: 2022 VS 2033
Figure 13. Global Radiotheranostic Market Share by Players in 2022
Figure 14. Global Top Radiotheranostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiotheranostic as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Radiotheranostic Revenue in 2022
Figure 16. North America Radiotheranostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 17. North America Radiotheranostic Market Share by Country (2018-2033)
Figure 18. United States Radiotheranostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. Canada Radiotheranostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Europe Radiotheranostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Radiotheranostic Market Share by Country (2018-2033)
Figure 22. Germany Radiotheranostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. France Radiotheranostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. U.K. Radiotheranostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Italy Radiotheranostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Russia Radiotheranostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Nordic Countries Radiotheranostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Asia-Pacific Radiotheranostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Radiotheranostic Market Share by Region (2018-2033)
Figure 30. China Radiotheranostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Japan Radiotheranostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. South Korea Radiotheranostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Southeast Asia Radiotheranostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. India Radiotheranostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Australia Radiotheranostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Latin America Radiotheranostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Radiotheranostic Market Share by Country (2018-2033)
Figure 38. Mexico Radiotheranostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Brazil Radiotheranostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Middle East & Africa Radiotheranostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Radiotheranostic Market Share by Country (2018-2033)
Figure 42. Turkey Radiotheranostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Saudi Arabia Radiotheranostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. ITM Isotopen Technologien München AG Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 45. Advanced Accelerator Applications Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 46. Telix Pharmaceuticals Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 47. Theragnostics Ltd. Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 48. NuView Life Sciences Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 49. Jubilant Pharma Limited Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 50. Clarity Pharmaceuticals. Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 51. TransCode Therapeutics, Inc. Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 52. Curium SAS Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 53. GE Healthcare Inc. Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 54. Bayer AG Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 55. Lantheus Medical Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 56. Imaging, Inc. Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 57. Novartis AG Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 58. Spectrum Pharmaceuticals, Inc. Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 59. Ipsen S.A. Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 60. Actinium Pharmaceuticals, Inc. (ATNM) Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 61. Nordic Nanovector ASA Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 62. Y-mAbs Therapeutics, Inc. Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 63. Sofie Biosciences, Inc. Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 64. Terumo Corporation Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 65. Sirtex Medical Limited Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 66. Boston Scientific Corporation Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 67. Nihon Medi-Physics Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed